<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9435F54A-7BB8-418B-ABAC-DA209BA3CB40"><gtr:id>9435F54A-7BB8-418B-ABAC-DA209BA3CB40</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Hiom</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105184300"><gtr:id>325220C9-0D96-416C-95E5-7DBB3DA3C674</gtr:id><gtr:title>Cellular Responses to DNA damage in vertebrates</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105184300</gtr:grantReference><gtr:abstractText>Damage to DNA, the cells genetic material, may arise as a consequence of exposure to radiation or harmful chemicals, or because of mistakes during the process of replication, the process whereby the cell makes a new copy of its DNA. If left alone, this damage will lead to alterations, known as mutations, in the genetic code of the cell and perhaps changing a normal cell to a cancer cell. Therefore it is extremely important that these mistakes are corrected and the genetic code is preserved. To do this each cell has a collection of different tools with which to repair DNA damage. |Often cancer cells are found to have part of this toolkit and cannot carry out proper repair of their DNA. Consequently, cancer cells accumulate DNA breaks and improperly repaired DNA leading to unwanted changes in the cells genetic code. These genetic alterations mean that the cancer cell cannot function properly, which in turn leads to further DNA damage and even more mutations. |By studying how cells repair their DNA and the consequences of losing different DNA repair tools helps us to identify the important events that help turn a normal cell into a cancer cell. Importantly, these studies also help us to identify new ways to attack and either kill or slow the growth of cancer cells leading to improved survival for cancer patients.</gtr:abstractText><gtr:technicalSummary>Germline mutations in the BRCA1 gene predispose women to early onset, familial breast and ovarian cancer. Loss of BRCA1 in cells is associated with profound chromosomal instability and a high rate of spontaneous chromosome breakage. We are investigating the role played by BRCA1 in the repair of DNA damage and how specific defects in the function of this protein lead to the profound genomic instability that is prerequisite for the development of breast cancer. Using the powerful genetics of the chicken DT40 system, as well as an in vitro assay for biochemical function, we are investigating the role of BRCA1/BARD1 in mediating the cellular response to DNA damage. In particular we are attempting to relate the E3 ubiquitin ligase and BRCT phospho-protein binding functions of BRCA1 to its role in the maintenance of genomic stability. A proportion of this work focuses on a functional relationship between BRCA1 and the Fanconi anaemia pathway for repair of blocked replication forks. Recently this work uncovered a new human disease gene, the Fanconi anaemia complementation group J gene (FA-J). Understanding the function of FA-J is another clear goal of the group. |An additional area of research is the role of ubiquitin and ubiquitin-like molecules on cellular function. To this end we are investigating the role of SUMO modification on DNA repair and collaborate with Neil Brockdorffs group (MRC, Hammersmith) investigating the mechanism of the polycomb-mediated histone ubiquitination implicated in gene silencing and epigenetic programming. The latter involves the expression, purification and characterization of novel E3 ligase activities associated with members of the human and mouse polycomb complex.|</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2142227</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>Chromatin ubiquitylation and regulation of gene expression</gtr:description><gtr:id>ABFBF583-ADD2-4D97-B7FA-CC726A542425</gtr:id><gtr:impact>Publication of a paper on the role of polycomb complexes in the regulation of gene expression. Pub Med id 17936708</gtr:impact><gtr:outcomeId>59B627FD1A4-1</gtr:outcomeId><gtr:partnerContribution>Part time post-doctoral researcher working with my group</gtr:partnerContribution><gtr:piContribution>Provided consumables and infrastructure for proportion of the research effort</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>Function of FANCJ</gtr:description><gtr:id>507312E0-4F14-4855-BF2A-D0D24B720A02</gtr:id><gtr:impact>Paper by London et al pubmed id 18978354</gtr:impact><gtr:outcomeId>CB8A25C024F-1</gtr:outcomeId><gtr:partnerContribution>Collaboration with Simon Boulton at Clare Hall laboratories on a comparative genome hybridization analysis of cells from a FA-J patient</gtr:partnerContribution><gtr:piContribution>Student research Fellowship and consumables for the biochemicalanalysis of FANCJ</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>149576</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>2D737172-3639-4D55-8D8A-1B4B76F3E7ED</gtr:id><gtr:outcomeId>041D55E73380</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>FANCJ 1 null mutant derived from avian DT40 cell line</gtr:description><gtr:id>3013724E-1411-4D39-BA4E-8EB0C227C4B1</gtr:id><gtr:impact>Identified human gene FANCJ leading to diagnosis for FANCJ patients</gtr:impact><gtr:outcomeId>F6FFC9C00E3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>FANCJ DT40 cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>BARD1 1 null mutant derived from avian DT40 cell line</gtr:description><gtr:id>BA0754DB-8E57-4FF4-9DB5-315EAF5A2155</gtr:id><gtr:impact>Only BARD1 null cell line available for genetic studies</gtr:impact><gtr:outcomeId>B3FCC21D80D</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BARD1 1  DT40 cell line</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>CtIP null mutant derived from avian DT40 cell line</gtr:description><gtr:id>7655FDE8-48C0-48F7-BA1E-F65DFAE7B926</gtr:id><gtr:impact>Somatic cell genetics showing how BRCA1 regulates repair of DNA damage in cell cycle dependent manner</gtr:impact><gtr:outcomeId>5C1E6FE684B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CtIP-DT40 cell line</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>BRCA1 null mutant derived from avian DT40 cell line</gtr:description><gtr:id>5C88FFD6-80A9-432D-933F-7FDD0CD83421</gtr:id><gtr:impact>enables somatic cell genetics of BRCA1 defect</gtr:impact><gtr:outcomeId>CA486145788</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DT40-BRCA1 mutant cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A8FAA1BF-100A-4104-B1DB-CE4067BE782E</gtr:id><gtr:title>A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55fef26697154c60010500045e9a6143"><gtr:id>55fef26697154c60010500045e9a6143</gtr:id><gtr:otherNames>Elderkin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>CE8D1E7EB74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D458B6E9-6EE4-4B71-A429-1A0BC4BC1991</gtr:id><gtr:title>DNA repair: common approaches to fixing double-strand breaks.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dc00a2fcebfb2a61cd7b3d7dbf0bef5"><gtr:id>2dc00a2fcebfb2a61cd7b3d7dbf0bef5</gtr:id><gtr:otherNames>Hiom K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>C10F2C64D53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72D68997-BC8D-4FD3-9FB3-B9BCBA5A573A</gtr:id><gtr:title>FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b9d525ccc6caab834e74c349cf044a"><gtr:id>28b9d525ccc6caab834e74c349cf044a</gtr:id><gtr:otherNames>London TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>22FDBCAF227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F800B174-82C3-4E50-9CBA-2A669768F8AA</gtr:id><gtr:title>CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e4a53eb97133f6e766ecb577b76f94f"><gtr:id>4e4a53eb97133f6e766ecb577b76f94f</gtr:id><gtr:otherNames>Yun MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>007AC334AD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8771FBAA-3053-4788-9D1E-6EC7CA7C617C</gtr:id><gtr:title>DNA repair: a riddle at a double-strand break.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dc00a2fcebfb2a61cd7b3d7dbf0bef5"><gtr:id>2dc00a2fcebfb2a61cd7b3d7dbf0bef5</gtr:id><gtr:otherNames>Hiom K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>FE2C715E316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEE13E96-98D0-4C04-9344-2A592FF11008</gtr:id><gtr:title>Understanding the functions of BRCA1 in the DNA-damage response.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e4a53eb97133f6e766ecb577b76f94f"><gtr:id>4e4a53eb97133f6e766ecb577b76f94f</gtr:id><gtr:otherNames>Yun MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>E5817626DF0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105184300</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>